1. Home
  2. HAE vs AVNT Comparison

HAE vs AVNT Comparison

Compare HAE & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • AVNT
  • Stock Information
  • Founded
  • HAE 1971
  • AVNT 1927
  • Country
  • HAE United States
  • AVNT United States
  • Employees
  • HAE N/A
  • AVNT N/A
  • Industry
  • HAE Medical/Dental Instruments
  • AVNT Major Chemicals
  • Sector
  • HAE Health Care
  • AVNT Industrials
  • Exchange
  • HAE Nasdaq
  • AVNT Nasdaq
  • Market Cap
  • HAE 3.8B
  • AVNT 4.4B
  • IPO Year
  • HAE 1991
  • AVNT 1993
  • Fundamental
  • Price
  • HAE $91.05
  • AVNT $50.92
  • Analyst Decision
  • HAE Strong Buy
  • AVNT Strong Buy
  • Analyst Count
  • HAE 8
  • AVNT 5
  • Target Price
  • HAE $107.88
  • AVNT $54.50
  • AVG Volume (30 Days)
  • HAE 695.6K
  • AVNT 523.4K
  • Earning Date
  • HAE 11-07-2024
  • AVNT 10-31-2024
  • Dividend Yield
  • HAE N/A
  • AVNT 2.11%
  • EPS Growth
  • HAE N/A
  • AVNT N/A
  • EPS
  • HAE 2.41
  • AVNT 1.64
  • Revenue
  • HAE $1,361,223,000.00
  • AVNT $3,212,900,000.00
  • Revenue This Year
  • HAE $7.71
  • AVNT $5.38
  • Revenue Next Year
  • HAE $4.89
  • AVNT $4.41
  • P/E Ratio
  • HAE $37.83
  • AVNT $31.21
  • Revenue Growth
  • HAE 9.84
  • AVNT N/A
  • 52 Week Low
  • HAE $70.25
  • AVNT $33.64
  • 52 Week High
  • HAE $97.97
  • AVNT $54.68
  • Technical
  • Relative Strength Index (RSI)
  • HAE 75.64
  • AVNT 61.71
  • Support Level
  • HAE $70.25
  • AVNT $51.00
  • Resistance Level
  • HAE $94.99
  • AVNT $52.36
  • Average True Range (ATR)
  • HAE 2.49
  • AVNT 1.56
  • MACD
  • HAE 2.09
  • AVNT 0.36
  • Stochastic Oscillator
  • HAE 86.84
  • AVNT 68.66

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About AVNT Avient Corporation

Avient Corp manufactures and sells a variety of chemical and plastic-based products to designers and processors of plastics. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.

Share on Social Networks: